Health & Biotech
InteliCare lands MercyCare contract to provide AI-based smart tech for independent living
Health & Biotech
Osteopore granted patent in China, makes a move into the big Chinese market
Health & Biotech
ASX Health Stocks: Intelicare jumps 35pc on AI in-home sensor tech contract for seniors
Health & Biotech
ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress
Health & Biotech
Osteopore Ltd books improvement in gross margins as it eyes a strong pipeline of post-COVID sales opportunities
Health & Biotech
Little Green Pharma ready to slide into international cannabis markets
Health & Biotech
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare
Health & Biotech
Dr Boreham’s Crucible: Breaking down the post-COVID market opportunity for Uscom
Health & Biotech
ASX pot stocks tap the capital markets as ECS and Cann Global announce capital raisings
Health & Biotech
Opyl tips growing demand for its clinical trial recruitment platform post-lockdown
Health & Biotech
TALi Digital positions itself at centre of global digital therapeutics during September quarter
Health & Biotech
PharmAust makes important progress during quarter ahead of multiple clinical trials of lead drug, monepantel
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.